Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
UFP Technologies, Inc. is a U.S.-based advanced manufacturing company that designs and produces custom-engineered components, products, and specialty packaging solutions. The company primarily operates in the medical device, healthcare, automotive, industrial, and consumer end markets, with a strategic emphasis on high-value, regulated applications. Its core offerings include sterile barrier packaging, molded components, engineered foams, films, plastics, and precision-manufactured assemblies used in mission-critical applications.
The company’s primary revenue driver is its Medical business, which serves leading medical device and healthcare companies with custom packaging and device components designed to meet stringent regulatory and performance requirements. UFP Technologies is positioned as a value-added partner rather than a commodity supplier, leveraging engineering expertise, materials science capabilities, and quality systems as strategic advantages. Founded in 1963, the company evolved from a regional foam products manufacturer into a diversified advanced manufacturing platform, with a transformation over the past two decades toward regulated medical and healthcare markets through organic growth and acquisitions.
Business Operations
UFP Technologies operates through integrated manufacturing facilities that support multiple end markets, with its operations organized primarily around Medical and Non-Medical business activities. The Medical segment includes sterile packaging systems, infection prevention components, single-use medical device components, and specialty films and foams, and represents the majority of consolidated revenue. The Non-Medical operations serve automotive, industrial, aerospace, and consumer markets with engineered materials and protective solutions.
The company maintains domestic manufacturing operations across multiple U.S. states and supplements these with select international facilities to support global customers. UFP Technologies controls proprietary manufacturing processes, tooling, and material conversion technologies, enabling customization at scale. Growth has been supported by acquired subsidiaries that expand medical packaging, device component manufacturing, and cleanroom capabilities; however, the specific contribution of individual subsidiaries varies by product line and customer program.
Strategic Position & Investments
UFP Technologies’ strategy centers on deepening its presence in regulated, higher-margin markets, particularly medical devices and healthcare packaging. Growth initiatives focus on expanding cleanroom manufacturing, increasing exposure to recurring medical programs, and cross-selling capabilities across acquired businesses. The company has consistently pursued bolt-on acquisitions to enhance technical capabilities, geographic reach, and customer relationships within the medical sector.
Recent investments have emphasized acquired company names in medical packaging, infection prevention, and specialty device components, integrating them into a unified operating platform. The company also invests in automation, process validation, and quality systems to meet evolving regulatory requirements. Exposure to emerging healthcare technologies is primarily indirect, through components and packaging used in minimally invasive devices, diagnostics, and single-use medical systems. Where acquisition-specific financial impacts are not publicly disaggregated, data inconclusive based on available public sources.
Geographic Footprint
UFP Technologies is headquartered in the United States, with its principal executive offices in Massachusetts. The company operates a network of manufacturing and engineering facilities across North America, with additional operations in Europe and Asia to support multinational customers and global medical device supply chains.
Its geographic footprint is designed to provide proximity to customer manufacturing hubs and to meet regional regulatory and logistics requirements. While the majority of revenue is generated in the United States, international operations play a strategic role in serving global healthcare and industrial customers and supporting long-term growth initiatives.
Leadership & Governance
UFP Technologies is led by an executive team with long-standing experience in advanced manufacturing, regulated industries, and acquisition integration. The leadership philosophy emphasizes operational discipline, customer partnership, and capital allocation focused on long-term value creation, particularly in medical and healthcare markets.
Key executives include:
- R. Jeffrey Bailly – Chief Executive Officer
- Christopher P. Litterio – Chief Financial Officer
- John J. McGrath Jr. – Chairman of the Board
Additional executive roles and succession planning details are disclosed in SEC filings, though certain operational leadership responsibilities below the C-suite level are not consistently detailed across public sources; data inconclusive based on available public sources.